

Novel Agents and Strategies in Lung Cancer
Aug 13, 2024
Dr. Melissa Johnson from Sarah Cannon Research Institute, Dr. Ticiana Leal from Winship Cancer Institute, and Dr. Manish Patel from Florida Cancer Specialists dive into the latest advancements in lung cancer treatment. They discuss the promising role of telemedicine and palliative care, especially during the COVID pandemic. The potential of B7H3 as a treatment target is explored, alongside innovative therapies like Tarlatumab and novel drug combinations. Insights from recent clinical trials reveal exciting strategies aimed at improving patient outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 4min
Telemedicine & Palliative Care in Lung Cancer
04:17 • 3min
Telemedicine and TDXD: Innovations in Lung Cancer Treatment
07:41 • 9min
Exploring B7H3: A Novel Target in Lung Cancer Therapy
16:15 • 6min
Innovative Approaches in Lung Cancer Treatment
21:54 • 23min
Exploring Treatment Strategies for Aggressive Lung Adenocarcinoma
45:06 • 2min
Tarlatumab Approval: Insights from the Delphi 301 Study
47:17 • 4min
Advancements in Lung Cancer Treatment
50:51 • 11min